BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 37706060)

  • 1. Prognosis and Biological Function of miR-3195 in Non-Small Cell Lung Cancer [Retraction].
    Cancer Manag Res; 2023; 15():1265-1266. PubMed ID: 38027243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction].
    Cancer Manag Res; 2023; 15():1267-1268. PubMed ID: 38027244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Down-Regulation of TrkB Alleviates the Malignant Biological Behavior and Cancer Stem-Like Property of Laryngeal Cancer [Retraction].
    Cancer Manag Res; 2024; 16():639-640. PubMed ID: 38912516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Effect of miR497-5p-
    Cancer Manag Res; 2023; 15():1339-1340. PubMed ID: 38027234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NPTX1 Promotes Metastasis via Integrin/FAK Signaling in Gastric Cancer [Retraction].
    Cancer Manag Res; 2023; 15():1123-1124. PubMed ID: 37842129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCT4 Accelerates Tumorigenesis Through Activating JAK/STAT Signaling in Ovarian Cancer Side Population Cells [Retraction].
    Cancer Manag Res; 2024; 16():281-282. PubMed ID: 38601904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK-STAT Domain Enhanced MUC1-CAR-T Cells Induced Esophageal Cancer Elimination [Retraction].
    Cancer Manag Res; 2024; 16():641-642. PubMed ID: 38915374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Chloride Channel-3 Predicts Unfavorable Prognosis and Promotes Cellular Invasion in Gastric Cancer [Retraction].
    Cancer Manag Res; 2024; 16():465-466. PubMed ID: 38778798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1307324. PubMed ID: 37927471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil Combined with Rutaecarpine Synergistically Suppresses the Growth of Colon Cancer Cells by Inhibiting STAT3 [Retraction].
    Drug Des Devel Ther; 2024; 18():2403-2404. PubMed ID: 38911031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells.
    Liang X; Xu C; Wang W; Li X
    Stem Cells Int; 2019; 2019():7028901. PubMed ID: 31781245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNMT1/miR-34a/FOXM1 Axis Contributes to Stemness of Liver Cancer Cells.
    Cao X; Liu L; Cao X; Cui Y; Zou C; Chen A; Qiu Y; Quan M; Ren K; Chen X; Cao J
    J Oncol; 2020; 2020():8978930. PubMed ID: 32308683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.
    Yang Z; Liu T; Ren X; Yang M; Tu C; Li Z
    Cell Cycle; 2022 Oct; 21(20):2121-2131. PubMed ID: 35699451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isovitexin Suppresses Cancer Stemness Property and Induces Apoptosis of Osteosarcoma Cells by Disruption of the DNMT1/miR-34a/Bcl-2 Axis [Retraction].
    Cancer Manag Res; 2023; 15():1003-1004. PubMed ID: 37706060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis.
    Liang X; Xu C; Cao X; Wang W
    Cancer Manag Res; 2019; 11():8923-8936. PubMed ID: 31686915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isovitexin Inhibits Stemness and Induces Apoptosis in Hepatocellular Carcinoma SK-Hep-1 Spheroids by Upregulating miR-34a Expression.
    Xu C; Cao X; Cao X; Liu L; Qiu Y; Li X; Zhou L; Ning Y; Ren K; Cao J
    Anticancer Agents Med Chem; 2020; 20(14):1654-1663. PubMed ID: 32329692
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.